Tirzepatide and pregnancy: what the evidence says, and what to do

Step 1: If you discover you are pregnant while taking tirzepatide

Stop treatment and contact your GP or obstetric team the same day if you can. This is not a situation to manage alone. If you want to understand the full picture before speaking to your doctor, you can read our detailed guidance on pregnancy and tirzepatide, which covers what the prescribing information says and why the precautionary guidance is so consistent. Those studies were conducted in animals rather than humans, and there is no controlled trial data in pregnant people (because running such trials would be ethically impossible), but the precautionary guidance is clear and consistent.

The NHS medicines page for tirzepatide advises stopping the medicine and seeking medical advice immediately if pregnancy occurs during treatment. Your GP will want to review your overall care plan, flag the exposure to your maternity team, and make sure you have appropriate monitoring in place. Weight management during pregnancy is a specialist conversation, not something tirzepatide is part of.

Try to note roughly how far along you were in your treatment, which dose you were on, and when you last injected. Your clinical team will find that information useful.

Step 2: Understand the contraception guidance before you start treatment

This is one of the most practically important points for anyone of reproductive age considering tirzepatide. The medicine slows gastric emptying — the rate at which your stomach processes food and, by extension, oral medicines. In the first four weeks of treatment, and for four weeks following any dose increase, oral contraceptive pills may be absorbed less reliably.

The NHS England guidance on weight-management injections specifically advises adding a barrier method (such as condoms) during those windows, rather than relying on the pill alone. This is not a permanent restriction, once you have been stable on a dose for four weeks, the absorption concern resolves for that dose level. But it matters most at the start of treatment and every time your dose steps up.

Non-oral hormonal contraception (patches, the ring, implants, injections, hormonal coils) is not affected by this absorption issue, and transdermal HRT falls into the same low-risk category. If you use the pill and you are thinking about starting tirzepatide, it is worth having this conversation with a prescriber before your first pen arrives. Our clinical team covers this during the consultation, you can read more about tirzepatide's effects on fertility and contraception if that is relevant to your situation.

Step 3: Plan the wash-out period if you want to conceive

If you are hoping to become pregnant in the near future, tirzepatide needs to stop before conception. The MHRA advises using effective contraception while on GLP-1 receptor agonist medicines and for a wash-out period before trying to conceive. Your prescriber will guide you on the exact timing based on your individual circumstances, this is not a one-size answer.

Weight loss itself, which tirzepatide can support, may improve fertility for some people by improving hormonal balance and ovulatory function. That is a separate, positive clinical consideration, discussed in more detail on our page about Mounjaro's relationship with pregnancy outcomes. But the medicine itself should not be present when conception occurs.

If you have already become pregnant while on the medication, our page covering what to do if you find yourself pregnant on tirzepatide sets out the practical next steps in more detail. Once you have stopped tirzepatide with a view to conceiving, your GP or specialist is the right person to co-ordinate what happens next, including any dietary or lifestyle support to maintain the gains made during treatment. Our prescribers can also help you think through the timing, check your eligibility to start a conversation.

Step 4: Know what is still uncertain, and who holds the answers

Honest medicine involves acknowledging what is not yet known. Human data on tirzepatide in pregnancy is very limited. The not-recommended guidance is precautionary, which is appropriate when a medicine is new and the stakes are high. It does not mean that everyone exposed to tirzepatide before a confirmed pregnancy will face harm, but it does mean that any such situation warrants prompt, specialist review rather than reassurance from a general article.

Some questions that commonly arise (whether weight lost on tirzepatide persists after stopping, whether previous treatment affects pregnancy health outcomes, and what the longer-term metabolic picture looks like) sit with your obstetric team, endocrinologist, or GP. If you are uncertain where to start, our FAQs cover some of the broader treatment questions, and our clinical team can advise on the prescribing side. For the pregnancy care itself, specialist obstetric input is the right route.

The question of how tirzepatide interacts with the liver is occasionally raised in pregnancy contexts too, our liver page covers what is known about that separately. Lifestyle questions also come up during this period, and if you are wondering whether alcohol fits into the picture, our page on whether you can drink on Mounjaro addresses that in plain terms.